CB
57
3
ABBV
59
2
HBI
61
11
INTU
76
-2
MPC
44
2
EXPD
27
-4
HST
32
-2
ICE
69
2
CMS
57
4
SYF
60
-2
ALLE
57
2
AMG
47
-5
GILD
63
-2
XEL
64
6
FRT
56
-2
STI
18
-3
REGN
31
-14
PNC
63
-2
NFLX
76
3
CVS
58
2
CB
57
3
ABBV
59
2
HBI
61
11
INTU
76
-2
MPC
44
2
EXPD
27
-4
HST
32
-2
ICE
69
2
CMS
57
4
SYF
60
-2
ALLE
57
2
AMG
47
-5
GILD
63
-2
XEL
64
6
FRT
56
-2
STI
18
-3
REGN
31
-14
PNC
63
-2
NFLX
76
3
CVS
58
2
Financhill
Back

Vor Biopharma Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21

VOR
Vor Biopharma

Last Price:
$0.22
Seasonality Move:
-22.98%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VOR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Vor Biopharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.18 Buy
20-day SMA: 0.26 Sell
50-day SMA: 0.52 Sell
200-day SMA: 0.88 Sell
8-day EMA: 0.19 Buy
20-day EMA: 0.28 Sell
50-day EMA: 0.5 Sell
200-day EMA: 0.94 Sell

Vor Biopharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 26.89 Sell
Chaikin Money Flow: 562507 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.11 - 0.57) Sell
Bollinger Bands (100): (0.45 - 1.33) Sell

Vor Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Vor Biopharma Stock

Is Vor Biopharma Stock a Buy?

  • Vor Biopharma share price is 0.20 while VOR 8-day simple moving average is 0.18, which is a Buy signal.
  • The stock price of VOR is 0.20 while Vor Biopharma 20-day SMA is 0.26, which makes it a Sell.
  • Vor Biopharma 50-day simple moving average is 0.52 while VOR share price is 0.20, making it a Sell technically.
  • VOR stock price is 0.20 and Vor Biopharma 200-day simple moving average is 0.88, creating a Sell signal.

VOR Technical Analysis vs Fundamental Analysis

Sell
21
Vor Biopharma (VOR) is a Sell

Is Vor Biopharma a Buy or a Sell?

  • Vor Biopharma stock is rated a Sell
    The current Vor Biopharma [VOR] share price is $0.20. The Score for VOR is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.

Vor Biopharma Stock Info

Market Cap:
25M
Price in USD:
0.20
Share Volume:
1.9M

Vor Biopharma 52-Week Range

52-Week High:
1.80
52-Week Low:
0.13
Sell
21
Vor Biopharma (VOR) is a Sell

Vor Biopharma Share Price Forecast

  • What is the Vor Biopharma stock price today?
    The Vor Biopharma stock price is 0.20 USD today.
  • Will VOR stock go up or go down?
    Vor Biopharma> share price is forecast to RISE/FALL based on technical indicators
  • Is Vor Biopharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vor Biopharma is overvalued.

Is Vor Biopharma Stock a Buy?

  • Vor Biopharma share price is 0.20 while VOR 8-day exponential moving average is 0.19, which is a Buy signal.
  • The stock price of VOR is 0.20 while Vor Biopharma 20-day EMA is 0.28, which makes it a Sell.
  • Vor Biopharma 50-day exponential moving average is 0.50 while VOR share price is 0.20, making it a Sell technically.
  • VOR stock price is 0.20 and Vor Biopharma 200-day simple moving average is 0.94, creating a Sell signal.

Fundamental Analysis of Vor Biopharma

Is Vor Biopharma a good investment?

  • Analysts estimate an earnings increase this quarter of $0.29 per share, an increase next quarter of $0.03 per share, an increase this year of $0.82 per share, and an increase next year of $0.30 per share.

Technical Analysis of Vor Biopharma

Should I short Vor Biopharma stock?

* Vor Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.